Testing effectiveness (Phase 2)Study completedNCT00846989
What this trial is testing
Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension
Who this might be right for
GlaucomaOcular Hypertension
Novartis Pharmaceuticals 276